HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Innovation / September 2026

A closer look at the 21-filing innovation map.

Wound sensing, tissue repair and the shared platform connecting today’s product to tomorrow’s research.

Grid of 21 provisional filings: 10 wound care, 5 platform, 4 crossover, 2 peptides

Clear Health Pass filed 21 provisional patent applications September 15–21, 2026: ten in wound care, five in the shared platform, four crossover filings and two in peptides.

From wound status to research governance

Described functions include visual wound-status signals, biofilm detection and disruption, flowable tissue formats, battery-free monitoring, measurement and documentation, and tamper-evident audit records. Peptide and crossover concepts include metabolic and gut-focused research regimens and graft–research combinations.

These are provisional applications, not issued patents. Patent scope, issuance and commercialization are uncertain. The conversion window for the corresponding applications is September 15–21, 2027.